US Bancorp
RUBY

US Bancorp’s Rubius Therapeutics, Inc RUBY Stock Holding History

US Bancorp’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-336
Closed -$2K – 4305
2022
Q1 		$2K Sell
336
-950
-74% -$6.03K ﹤0.01% 3892
2021
Q4 		$12K Hold
1,286
– – ﹤0.01% 3372
2021
Q3 		$23K Sell
1,286
-44
-3% -$957 ﹤0.01% 3068
2021
Q2 		$32K Buy
1,330
+44
+3% +$1.1K ﹤0.01% 2895
2021
Q1 		$34K Hold
1,286
– – ﹤0.01% 2776
2020
Q4 		$10K Buy
+1,286
New +$7.64K ﹤0.01% 3192
2020
Q3 		– Sell
-203
Closed -$1K – 3908
2020
Q2 		$1K Sell
203
-59
-23% -$348 ﹤0.01% 3684
2020
Q1 		$1K Buy
+262
New +$1.95K ﹤0.01% 3636

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

US Bancorp's RUBY Position: Q2 2022 in Review

US Bancorp sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 336 shares — an estimated $2K sold.

US Bancorp first reported a position in RUBY in Q1 2020 and held it in 8 quarters. The position peaked at $34K in Q1 2021. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • US Bancorp reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • US Bancorp sold 336 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $2K.
  • US Bancorp first reported a position in Rubius Therapeutics, Inc in Q1 2020 and held it in 8 quarters.
  • US Bancorp's Rubius Therapeutics, Inc position peaked at $34K in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on US Bancorp's 13F filing for Q2 2022, filed 1 Aug 2022.